Abstract

COVID-19 with no antibody response in a multiple sclerosis patient treated with cladribine: Implication for vaccination program?

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call